Comparison of Clinical, Metabolic, Hormonal, and Ultrasound Parameters among the Clomiphene Citrate-Resistant and Clomiphene Citrate-Sensitive Polycystic Ovary Syndrome Women.
Sachdeva G, Gainder S, Suri V, Sachdeva N, Chopra S.
Metformin With or Without Clomiphene Citrate Versus Laparoscopic Ovarian Drilling With or Without Clomiphene Citrate to Treat Patients With Clomiphene Citrate-Resistant Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
Sun ML, Bai WP, Song QK, Wang HY, Gao GL, Zheng L, Wang XH.
Front Pharmacol. 2022 Jun 22;13:576458. doi: 10.3389/fphar.2022.576458. eCollection 2022.
PMID:35814214
Is the addition of metformin efficacious in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome? A structured literature review.
Evaluation of tumor necrosis factor alpha serum level in obese and lean women with clomiphene citrate-resistant polycystic ovary disease.
Seyam E, Hasan M, Khalifa EM, Ramadan A, Hefzy E.
Gynecol Endocrinol. 2017 Nov;33(11):892-898. doi: 10.1080/09513590.2017.1320383. Epub 2017 May 8.
PMID:28480767
Re: Combined coenzyme Q10 and clomiphene citrate for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome. El Refaeey A, Selem A, Badawy A. Reprod Biomed Online. 2014;29(1):119-24.
Comparison of the efficiency of clomiphene citrate and letrozole in combination with metformin in moderately obese clomiphene citrate-resistant polycystic ovarian syndrome patients.
Bjelica A, Trninić-Pjević A, Mladenović-Segedi L, Cetković N, Petrović D.